1 April 2024 false No description of principal activity Taxfiler 2024.6 6857583business:PrivateLimitedCompanyLtd2024-04-012025-03-31 68575832024-03-31 68575832024-04-012025-03-31 6857583business:AuditExemptWithAccountantsReport2024-04-012025-03-31 6857583business:FilletedAccounts2024-04-012025-03-31 68575832025-03-31 6857583business:Director12024-04-012025-03-31 6857583business:Director22024-04-012025-03-31 6857583business:RegisteredOffice2024-04-012025-03-31 68575832024-03-31 6857583core:WithinOneYear2025-03-31 6857583core:WithinOneYear2024-03-31 6857583core:AfterOneYear2025-03-31 6857583core:AfterOneYear2024-03-31 6857583core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 6857583core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 6857583core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 6857583core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 6857583core:PreviouslyStatedAmount2025-03-31 6857583core:PreviouslyStatedAmount2024-03-31 6857583business:SmallEntities2024-04-012025-03-31 6857583countries:EnglandWales2024-04-012025-03-31 6857583core:MotorVehicles2024-04-012025-03-31 6857583core:FurnitureFittings2024-04-012025-03-31 6857583core:Goodwill2024-03-31 6857583core:IntangibleAssetsOtherThanGoodwill2024-03-31 6857583core:Goodwill2025-03-31 6857583core:IntangibleAssetsOtherThanGoodwill2025-03-31 6857583core:LandBuildings2024-03-31 6857583core:MotorVehicles2024-03-31 6857583core:FurnitureFittings2024-03-31 6857583core:LandBuildings2025-03-31 6857583core:MotorVehicles2025-03-31 6857583core:FurnitureFittings2025-03-31 6857583core:LandBuildings2024-04-012025-03-31 68575832023-04-012024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 6857583 (England and Wales)
MMO Pharma Ltd Unaudited accounts for the year ended 31 March 2025
MMO Pharma Ltd Unaudited accounts Contents
Page
- 2 -
MMO Pharma Ltd Company Information for the year ended 31 March 2025
Directors
Tahira Ahmed Saher Shoaib
Company Number
6857583 (England and Wales)
Registered Office
4 Rectory Lane Glinton Peterborough PE6 7LR
Accountants
Griffin and Sage Limited 172 Park Road Peterborough PE1 2UF
- 3 -
MMO Pharma Ltd Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
93,576 
93,857 
Current assets
Inventories
37,835 
41,127 
Debtors
378,777 
345,734 
Cash at bank and in hand
14,314 
1,087 
430,926 
387,948 
Creditors: amounts falling due within one year
(144,967)
(135,797)
Net current assets
285,959 
252,151 
Total assets less current liabilities
379,535 
346,008 
Creditors: amounts falling due after more than one year
(59,248)
(59,262)
Provisions for liabilities
Deferred tax
(190)
(244)
Net assets
320,097 
286,502 
Capital and reserves
Called up share capital
10 
10 
Profit and loss account
320,087 
286,492 
Shareholders' funds
320,097 
286,502 
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 30 December 2025 and were signed on its behalf by
Tahira Ahmed Director Company Registration No. 6857583
- 4 -
MMO Pharma Ltd Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
MMO Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 6857583. The registered office is 4 Rectory Lane, Glinton, Peterborough, PE6 7LR.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
25% RB
Fixtures & fittings
15% RB
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
- 5 -
MMO Pharma Ltd Notes to the Accounts for the year ended 31 March 2025
4
Intangible fixed assets
Goodwill 
Other 
Total 
£ 
£ 
£ 
Cost
At 1 April 2024
36,000 
2,765 
38,765 
At 31 March 2025
36,000 
2,765 
38,765 
Amortisation
At 1 April 2024
36,000 
2,765 
38,765 
At 31 March 2025
36,000 
2,765 
38,765 
Net book value
At 31 March 2025
- 
- 
- 
5
Tangible fixed assets
Land & buildings 
Motor vehicles 
Fixtures & fittings 
Total 
£ 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At cost 
At 1 April 2024
92,574 
7,010 
1,071 
100,655 
At 31 March 2025
92,574 
7,010 
1,071 
100,655 
Depreciation
At 1 April 2024
- 
6,132 
666 
6,798 
Charge for the year
- 
220 
61 
281 
At 31 March 2025
- 
6,352 
727 
7,079 
Net book value
At 31 March 2025
92,574 
658 
344 
93,576 
At 31 March 2024
92,574 
878 
405 
93,857 
6
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
VAT
7,695 
7,479 
Accrued income and prepayments
162,155 
154,804 
Other debtors
208,927 
183,451 
378,777 
345,734 
7
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Trade creditors
89,106 
84,853 
Taxes and social security
19,098 
14,180 
Loans from directors
36,763 
36,764 
144,967 
135,797 
- 6 -
MMO Pharma Ltd Notes to the Accounts for the year ended 31 March 2025
8
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Bank loans
59,016 
59,016 
Other creditors
232 
246 
59,248 
59,262 
9
Average number of employees
During the year the average number of employees was 7 (2024: 6).
- 7 -